FDA urgently approves Moderna vaccine on 17 December 2020

Report by : Gan Yung Chyan, KUCINTA SETIA / Image : Video Screenshot

On 17 December 2020 (Thursday), the U.S. Food and Drug Administration (FDA) has urgently approved the second SARS-CoV-2 vaccine in the United States-the Modena vaccine.

The FDA advisory panel voted to approve the emergency use of the Moderna vaccine (Moderna) on Thursday afternoon.

The result of the vote was 20-0, and one of the committee members abstained.

The press statement of FDA on 17 December 2020 reads, "Following today’s positive advisory committee meeting outcome regarding the Moderna COVID-19 vaccine, the U.S. Food and Drug Administration has informed the sponsor that it will rapidly work toward finalization and issuance of an emergency use authorization. The agency has also notified the U.S. Centers for Disease Control and Prevention and Operation Warp Speed, so they can execute their plans for timely vaccine distribution."

With the continuous surge in covi cases in the United States, the authorization to use Modena vaccine has cleared the way for urgent mass distribution of vaccines to curb the pandemic. 5.9 million doses of Modena vaccine will be ready to be shipped to all parts of the United States at any time initially.

Ref: https://www.fda.gov/news-events/press-announcements/fda-statement-vaccines-and-related-biological-products-advisory-committee-meeting-0